CHEK1 and cancer: Recent work using loss-of-function siRNA screens or small molecule Chk1 inhibitors have begun to identify tumor types where Chk1 is critical for cancer cell proliferation and/or viability in the absence of a DNA damaging chemotherapeutic agent.